Gossamer Bio is trading at $10.16 (5.3% down) as the stock experiences ongoing volatility following its 1-for-80 reverse stock split.

  • The reverse split became effective September 10, 2026, with split-adjusted trading commencing September 11 to help the company regain Nasdaq listing compliance.
  • Under the terms of the corporate action, every 80 shares of existing common stock were consolidated into one share.
  • The downward movement occurs amid broader weakness in U.S. markets, though no new company-specific announcements were identified for September 14.